查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085306

心臟麻痹治療市場：依治療類型、年齡層、通路和最終用戶分類－2026-2032年全球市場預測

Cardiac Arrest Treatment Market by Treatment Type, Age Group, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟麻痹治療市場將成長至 485.3 億美元，複合年成長率為 9.54%。

主要市場統計數據
基準年 2025 256.3億美元
預計年份：2026年 277億美元
預測年份 2032 485.3億美元
複合年成長率 (%) 9.54%

心臟麻痹治療是一場與時間的賽跑，涵蓋早期發現、緊急醫療干預、高品質的心肺復甦術（CPR）、快速去心房顫動、高級生命支持、心臟麻痹後重症監護和復健。臨床和商業性的優先事項都很明確。延遲進行心肺復甦術或去心房顫動大幅降低存活率，但公共場所配備心肺復甦設備和自動體外心臟去心房顫動（AED）可以提高患者的生存率，並帶來良好的神經預後。

該市場由對自動體外心臟去心房顫動(AED)、手動去心房顫動、心肺復甦反饋裝置、復甦藥物、靶向體溫管理系統、體外心肺復甦術 (CPR) 以及綜合急救醫療服務流程的需求所驅動。來自美國心臟協會 (AHA)、國際復甦聯合委員會 (ILCOR)、歐洲復甦委員會 (ERC)、世界衛生組織 (WHO) 以及各國心臟麻痹登記資料的證據均支持一個共同的主題：決定治療結果的並非單一產品，而是醫療體系。

心臟麻痹治療的變革性變化

心臟麻痹的治療方法正從臨時性的緊急應變轉向整合的、數據驅動的復甦系統。公共去心房顫動計畫、調度員提供的CPR支援、移動救護車的部署、學校和職場的CPR培訓以及即時CPR品質回饋正成為社區生存策略的核心。醫院也在規範心臟麻痹後的治療流程，包括冠狀動脈評估、血流動力學最佳化、在臨床適用的情況下進行體溫管理、癲癇發作控制、通氣最佳化、復健計畫以及系統性的神經系統預後評估。

人工智慧（AI）的累積影響

人工智慧 (AI) 對心臟麻痹的治療正產生日益顯著的影響，涵蓋預防、檢測、回應和心臟麻痹後護理等各個環節。 AI 對緊急呼叫的分析能夠幫助調度員識別疑似心臟麻痹病例，而地理空間分析則可以根據以往的事件密度、人口流動情況和響應時間差來最佳化自動體外除顫器 (AED) 的放置位置。穿戴式裝置和遠端監測平台也為更早檢測心律不整風險提供了更多機會，尤其是在心血管疾病高風險族群。

按地區分類的主要發現

北美憑藉其成熟的急救醫療服務（EMS）系統、自動體外除顫器（AED）的廣泛應用、積極的註冊計劃參與以及指南的全面實施，仍然是心臟麻痹治療領域的主導地區。根據美國心臟協會（AHA）統計，美國每年報告超過35.6萬例院外心臟麻痹，因此快速心肺復甦術（CPR）和去心房顫動已成為一項重要的公共衛生優先事項。加拿大透過完善的省級心臟麻痹網路、公共去心房顫動計劃和社區急救員計劃，進一步加強了這項工作。

關鍵群體特定見解

在東協地區，由於都市化進程加快、心血管疾病負擔加重以及對急救醫療投入的增加，心臟麻痹治療領域湧現出巨大的發展機會。在政府大力支持心肺復甦術（CPR）教育、救護車現代化以及在機場、購物中心、交通樞紐、學校和職場等公共場所安裝自動體外心臟去顫器（AED）的地區，市場發展最為迅速。在潮濕、交通繁忙的環境以及公私急救模式並存的系統中，高度互通性且維護成本低的AED系統尤其重要。

主要國家的概況

美國在心臟麻痹治療創新、透過註冊登記提升醫療品質以及部署聯網自動體外心臟去顫器（AED）方面處於世界領先地位，並輔以循證復甦指南和大規模緊急醫療服務（EMS）系統。加拿大則強調省級醫療保健、社區心肺復甦術（CPR）以及公共場所配備除顫去心房顫動。墨西哥和巴西正在擴大其緊急醫療服務，這主要是由於都市區EMS基礎設施不足、對私立醫院的投資以及心血管疾病高發所致。

為行業領導者提供的實用建議

產業領導者應將心臟麻痹治療方案定位為以治療效果為中心的系統，而非獨立的醫療設備。優先措施包括：在風險較高地區和人流密集場所擴大公共場所自動體外除顫器 (AED) 的普及範圍；整合設備運作監控；鼓勵調度員提供心肺復甦 (CPR) 支援；以及利用具有反饋功能和情景式學習的人體模型進行定期培訓。

調查方法

本執行摘要是透過對檢驗的二手資料進行系統性回顧而編寫的，資訊來源包括復甦指南、國家和地方心臟麻痹登記處、同行評審的臨床文獻、監管文件、公共衛生出版物以及急救醫療服務績效框架。一手資料來源包括美國心臟協會 (AHA)、國際復甦聯合委員會 (ILCOR)、歐洲復甦委員會 (ERC)、世界衛生組織 (WHO) 以及（如有）國家級衛生機構。

結論

心臟麻痹治療正發展成為一個以早期發現、即時心肺復甦術 (CPR)、快速去心房顫動、高級復甦和循證心臟麻痹護理為核心的相互關聯的生態系統。最大的市場機會在於提高可衡量的生存率、完善營運基礎設施、實現公平的醫療服務取得以及推廣可擴展的培訓。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心臟麻痹治療市場：依治療類型分類

  • 心肺復甦設備
    • 負載分配帶裝置
    • 活塞驅動裝置
    • 氣動背心式裝置
  • 去心房顫動
    • 自動體外心臟去心房顫動
    • 植入式心臟整流去顫器
    • 穿戴式心臟去心房顫動
  • 藥物治療
  • 低溫療法系統
  • 監控系統
    • 二氧化碳監測系統
    • 心電圖監測儀

第8章：心臟麻痹治療市場：依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第9章：心臟麻痹治療市場：依分銷管道分類

  • 離線
  • 線上

第10章：心臟麻痹治療市場：依最終用戶分類

  • 門診部
  • 緊急醫療服務
  • 居家照護
  • 醫院

第11章心臟麻痹治療市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：心臟麻痹治療市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：心臟麻痹治療市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Boston Scientific Corporation
  • Cipla Limited
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fukuda Denshi Co., Ltd.
  • Jant Pharmacal Corporation
  • Johari Digital India Limited by Syrma SGS
  • Koninklijke Philips NV
  • LifeSign LLC
  • LifeSync
  • Luminex Corporation by DiaSorin SpA
  • Mitsubishi Chemical Group Corporation
  • Nexus Dx, Inc
  • Nihon Kohden Corporation
  • Quidel Corporation
  • Schiller AG
  • Shenzhen EDAN Instrument Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Spectral Diagnostics Inc.
  • Trinity Biotech PLC
Product Code: MRR-433AB1DC2886

The Cardiac Arrest Treatment Market is projected to grow by USD 48.53 billion at a CAGR of 9.54% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 25.63 billion
Estimated Year [2026] USD 27.70 billion
Forecast Year [2032] USD 48.53 billion
CAGR (%) 9.54%

Cardiac arrest treatment is a time-critical continuum that spans early recognition, emergency medical dispatch, high-quality cardiopulmonary resuscitation, rapid defibrillation, advanced life support, post-arrest intensive care, and rehabilitation. The clinical and commercial priority is clear: survival declines sharply when CPR and defibrillation are delayed, while bystander CPR and public-access automated external defibrillators improve the probability of neurologically favorable survival.

The market is shaped by demand for automated external defibrillators, manual defibrillators, CPR feedback devices, resuscitation drugs, targeted temperature management systems, extracorporeal cardiopulmonary resuscitation, and integrated emergency medical services workflows. Evidence from the American Heart Association, International Liaison Committee on Resuscitation, European Resuscitation Council, World Health Organization, and national cardiac arrest registries supports a consistent theme: systems of care, not single products, drive outcomes.

Transformative Shifts in the Cardiac Arrest Treatment Landscape

The cardiac arrest treatment landscape is shifting from episodic emergency response toward integrated, data-enabled resuscitation systems. Public-access defibrillation programs, dispatcher-assisted CPR, mobile responder activation, school and workplace CPR training, and real-time CPR quality feedback are becoming central to community survival strategies. Hospitals are also standardizing post-cardiac arrest pathways that include coronary evaluation, hemodynamic optimization, temperature control where clinically appropriate, seizure management, ventilation optimization, rehabilitation planning, and structured neuroprognostication.

Medical technology suppliers are responding with connected AED fleets, cloud-based device readiness monitoring, waveform analytics, and interoperable documentation tools. Health systems and EMS agencies are prioritizing measurable performance indicators, including call-to-compression time, collapse-to-shock time, chest compression fraction, return of spontaneous circulation, survival to discharge, and cerebral performance outcomes. This transformation favors organizations that can combine clinically validated devices with training, service support, analytics, and compliance-ready data infrastructure.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing cardiac arrest treatment across prevention, detection, response, and post-arrest care. AI-enabled emergency call analysis can support dispatchers in recognizing suspected cardiac arrest, while geospatial analytics can optimize AED placement based on historical incident density, population flow, and response-time gaps. Wearables and remote monitoring platforms are also expanding the opportunity for earlier recognition of arrhythmia risk, particularly in high-risk cardiovascular populations.

In clinical operations, AI can help analyze CPR quality, predict deterioration in monitored patients, support intensive care risk stratification, and improve resource coordination. However, adoption depends on validated performance, bias assessment, explainability, cybersecurity, privacy protection, and regulatory oversight. The strongest near-term value will come from human-in-the-loop tools that reduce delays, strengthen protocol adherence, and generate auditable quality improvement data.

Key Regional Insights

North America remains a leading region for cardiac arrest treatment adoption due to mature EMS systems, widespread AED deployment, active registry participation, and strong guideline implementation. The United States reports more than 356,000 out-of-hospital cardiac arrests annually, according to the American Heart Association, making rapid CPR and defibrillation a major public health priority. Canada adds strong provincial cardiac arrest networks, public-access defibrillation programs, and community responder initiatives.

Europe benefits from coordinated resuscitation guidelines, national and regional registries, and public-access defibrillation initiatives, although survival varies by country, EMS configuration, and local response capacity. The European Union is advancing emergency health digitization and medical device oversight, while the United Kingdom, Germany, France, Italy, Spain, and Russia continue to strengthen EMS modernization, hospital-based post-arrest care, and public education for early CPR.

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN countries increase emergency care investment, AED availability, and CPR education. Japan and Australia have well-established community defibrillation and OHCA reporting models, while India and several Southeast Asian countries present large unmet needs due to variable ambulance access, limited bystander CPR penetration, and uneven public AED coverage.

Latin America, the Middle East, and Africa show rising demand for defibrillators, emergency training, and hospital resuscitation capacity. Brazil and Mexico are regional anchors in Latin America, GCC countries are investing in smart emergency response infrastructure and ambulance connectivity, and African markets require scalable, lower-cost solutions for EMS coverage, AED access, maintenance reliability, and workforce training.

Key Group Insights

ASEAN presents a major opportunity for cardiac arrest treatment as urbanization, cardiovascular disease burden, and emergency care investment rise together. Market development is strongest where governments support CPR education, ambulance modernization, and public AED placement in airports, malls, transport hubs, schools, and workplaces. Interoperable, low-maintenance AED programs are especially relevant for humid, high-traffic environments and for systems with mixed public and private emergency response models.

The GCC is advancing premium emergency care through hospital investment, digital health strategies, and smart-city emergency response systems. Saudi Arabia, the United Arab Emirates, Qatar, and neighboring markets are prioritizing rapid response, connected ambulance systems, public-venue preparedness, and emergency readiness for large-scale events, supporting demand for reliable defibrillation, simulation-based training, and integrated dispatch workflows.

The European Union benefits from guideline harmonization, medical device regulation, and cross-border evidence generation, supporting demand for clinically validated defibrillation, CPR feedback, and post-arrest care technologies. BRICS markets represent scale and system diversity, with China and India driving broad access needs, Brazil and South Africa expanding public health infrastructure, and Russia maintaining strong hospital-based care networks despite regional procurement complexity.

G7 markets remain innovation leaders due to advanced EMS systems, higher healthcare spending, established clinical registries, and early adoption of connected medical devices. NATO members add demand linked to military medical readiness, mass-casualty preparedness, disaster response, and resilient emergency response networks, making ruggedized defibrillation, training systems, and deployable resuscitation solutions strategically important.

Key Country Insights

The United States leads in cardiac arrest treatment innovation, registry-driven quality improvement, and connected AED adoption, supported by evidence-based resuscitation guidelines and a large EMS base. Canada emphasizes provincial systems of care, community CPR, and public-access defibrillation. Mexico and Brazil are expanding emergency care capacity, with demand shaped by urban EMS gaps, private hospital investment, and high cardiovascular disease prevalence.

In Europe, the United Kingdom has strong resuscitation council guidance, ambulance performance monitoring, and public AED campaigns, while Germany combines advanced ambulance physician systems with high hospital capability. France emphasizes SAMU-based emergency coordination, Italy and Spain continue to expand public defibrillation access and CPR awareness, and Russia maintains significant hospital infrastructure but faces uneven regional deployment and procurement variation.

China is scaling emergency medicine capacity, AED installations, and CPR awareness across major cities. India has substantial unmet need due to high cardiovascular burden, variable ambulance coverage, and low community CPR penetration, creating demand for affordable AEDs, training, and hospital resuscitation protocols. Japan benefits from one of the world's most established public-access defibrillation networks and extensive out-of-hospital cardiac arrest registry evidence. Australia has strong EMS performance, community responder models, and public health programs supporting early defibrillation. South Korea continues to strengthen dispatcher-assisted CPR, public AED programs, and national registry-based improvement.

Across all countries, the most defensible opportunities align with guideline-concordant care, device readiness, user-friendly AED design, training retention, EMS integration, and measurable neurological survival outcomes rather than equipment procurement alone.

Actionable Recommendations for Industry Leaders

Industry leaders should position cardiac arrest treatment offerings as outcome-oriented systems rather than standalone devices. Priority actions include expanding public-access AED coverage in high-risk and high-traffic locations, integrating device readiness monitoring, supporting dispatcher-assisted CPR, and providing recurring training that uses feedback-enabled manikins and scenario-based learning.

Medical technology companies should invest in interoperability with EMS records, hospital electronic health records, and quality registries. Providers should track survival to discharge and neurological outcomes, not only return of spontaneous circulation. Public agencies and buyers should use evidence-based placement models, maintenance compliance, and response-time analytics to guide procurement. AI solutions should be deployed only with clinical validation, privacy safeguards, bias monitoring, cybersecurity controls, and clear accountability for human oversight.

Research Methodology

This executive summary is developed through a structured review of verified secondary evidence, including resuscitation guidelines, national and regional cardiac arrest registries, peer-reviewed clinical literature, regulatory materials, public health publications, and emergency medical services performance frameworks. Core sources include the American Heart Association, International Liaison Committee on Resuscitation, European Resuscitation Council, World Health Organization, and country-level health authorities where available.

The methodology prioritizes data consistency, clinical relevance, and market applicability. Insights are triangulated across epidemiology, treatment pathways, device adoption, reimbursement context, regional healthcare infrastructure, emergency response maturity, regulatory direction, and technology readiness. Forward-looking statements are limited to observable adoption patterns, documented policy priorities, and verified investment themes.

Conclusion

Cardiac arrest treatment is evolving into a connected ecosystem built around early recognition, immediate CPR, rapid defibrillation, advanced resuscitation, and evidence-based post-arrest care. The strongest market opportunities are tied to measurable survival improvement, operational readiness, equitable access, and scalable training.

Organizations that combine clinically validated technologies with analytics, EMS integration, reliable AED maintenance, and rigorous quality improvement will be best positioned to lead. As AI and connected devices mature, success will depend on trustworthy implementation that shortens time to treatment, supports clinical decision-making, and improves neurologically meaningful survival.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cardiac Arrest Treatment Market, by Treatment Type

  • 7.1. Cpr Devices
    • 7.1.1. Load Distributing Band Device
    • 7.1.2. Piston Driven Device
    • 7.1.3. Pneumatic Vest Device
  • 7.2. Defibrillator Devices
    • 7.2.1. Automated External Defibrillator
    • 7.2.2. Implantable Cardioverter Defibrillator
    • 7.2.3. Wearable Cardioverter Defibrillator
  • 7.3. Drug Therapies
  • 7.4. Hypothermia Systems
  • 7.5. Monitoring Systems
    • 7.5.1. Capnography Systems
    • 7.5.2. Ecg Monitors

8. Cardiac Arrest Treatment Market, by Age Group

  • 8.1. Adult
  • 8.2. Geriatric
  • 8.3. Pediatric

9. Cardiac Arrest Treatment Market, by Distribution Channel

  • 9.1. Offline
  • 9.2. Online

10. Cardiac Arrest Treatment Market, by End User

  • 10.1. Ambulatory Care Center
  • 10.2. Emergency Medical Services
  • 10.3. Home Care
  • 10.4. Hospital

11. Cardiac Arrest Treatment Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Cardiac Arrest Treatment Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Cardiac Arrest Treatment Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. ACON Laboratories Inc.
  • 15.3. Becton, Dickinson and Company
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. bioMerieux S.A.
  • 15.6. Boston Scientific Corporation
  • 15.7. Cipla Limited
  • 15.8. Danaher Corporation
  • 15.9. F. Hoffmann-La Roche Ltd.
  • 15.10. Fukuda Denshi Co., Ltd.
  • 15.11. Jant Pharmacal Corporation
  • 15.12. Johari Digital India Limited by Syrma SGS
  • 15.13. Koninklijke Philips N.V.
  • 15.14. LifeSign LLC
  • 15.15. LifeSync
  • 15.16. Luminex Corporation by DiaSorin S.p.A.
  • 15.17. Mitsubishi Chemical Group Corporation
  • 15.18. Nexus Dx, Inc
  • 15.19. Nihon Kohden Corporation
  • 15.20. Quidel Corporation
  • 15.21. Schiller AG
  • 15.22. Shenzhen EDAN Instrument Co., Ltd.
  • 15.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 15.24. Siemens Healthineers AG
  • 15.25. Spectral Diagnostics Inc.
  • 15.26. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC ARREST TREATMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CARDIAC ARREST TREATMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CARDIAC ARREST TREATMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CARDIAC ARREST TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CPR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CPR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CPR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LOAD DISTRIBUTING BAND DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOAD DISTRIBUTING BAND DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LOAD DISTRIBUTING BAND DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PISTON DRIVEN DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PISTON DRIVEN DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PISTON DRIVEN DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PNEUMATIC VEST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PNEUMATIC VEST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PNEUMATIC VEST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DEFIBRILLATOR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DEFIBRILLATOR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DEFIBRILLATOR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED EXTERNAL DEFIBRILLATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED EXTERNAL DEFIBRILLATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED EXTERNAL DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WEARABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WEARABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WEARABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DRUG THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DRUG THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DRUG THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HYPOTHERMIA SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPNOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPNOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPNOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ECG MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ECG MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ECG MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AMBULATORY CARE CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AMBULATORY CARE CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AMBULATORY CARE CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EMERGENCY MEDICAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EMERGENCY MEDICAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EMERGENCY MEDICAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOSPITAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOSPITAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOSPITAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. GCC CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. GCC CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. GCC CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. GCC CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GCC CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GCC CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. G7 CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. G7 CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. G7 CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 159. G7 CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. G7 CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. G7 CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NATO CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NATO CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. NATO CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. NATO CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. NATO CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. NATO CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. NATO CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 191. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 199. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 200. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 216. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 224. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 232. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 263. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 265. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 271. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 272. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 280. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY CPR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATOR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 287. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 288. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)